(Q43284687)

18 November 2017

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). (English)

1 reference

18 November 2017

1 reference

9

Laura J Havrilesky

1 reference

18 November 2017

Angeles Alvarez Secord

4

object named as

Angeles Alvarez Secord

1 reference

18 November 2017

1

Amanda Nickles Fader

1 reference

18 November 2017

3

Paola A Gehrig

1 reference

18 November 2017

11

Warner K Huh

1 reference

18 November 2017

7

Erin R Tuller

1 reference

18 November 2017

12

Allison E Axtell

1 reference

18 November 2017

13

Joseph L Kelley

1 reference

18 November 2017

14

Kristine M Zanotti

1 reference

18 November 2017

15

UPSC Consortium

1 reference

18 November 2017

David Starks

2

1 reference

18 November 2017

Heidi E Frasure

5

1 reference

18 November 2017

David M O'Malley

6

1 reference

18 November 2017

Peter G Rose

8

1 reference

18 November 2017

Kathleen N Moore

10

1 reference

18 November 2017

language of work or name

English

0 references

publication date

26 August 2009

1 reference

18 November 2017

1 reference

18 November 2017

115

1 reference

18 November 2017

2

1 reference

18 November 2017

244-248

1 reference

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

18 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Uterine papillary serous carcinoma: patterns of metastatic spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Outcomes in surgical stage I uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.07.030

10.1016/J.YGYNO.2009.07.030

7 January 2021

Identifiers

DOI

1 reference

18 November 2017

1 reference